Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-018130

Amphastar Pharmaceuticals, Inc. · AMPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Rong Zhou
Officer — EVP, Production Center
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 9:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001297184

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 16, 2017A11,797$0.00A48,788D
Common StockF2Mar 17, 2017F1,248$13.75D47,540D
Common StockF3holding———99,668ISee footnote
Common StockF4holding———5,000ISee footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F5$13.35Mar 16, 2017A29,424A—Mar 16, 2027Common Stock29,42429,424D

Explanation of responses